MedPath

sefulness of telemedicine in hypertensive outpatients: Cluster randomized controlled trial

Not Applicable
Conditions
Hypertension
Registration Number
JPRN-UMIN000040953
Lead Sponsor
Juntendo University
Brief Summary

Blood pressure control status and safety did not differ between the intervention and control groups. In-person visits at 6-month intervals may cause a societal cost reduction and improve patient satisfaction during video-based telemedicine.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
64
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with drug allergy (2) Pregnant patients (3) Patients who can not undertaken telemedicine, such as those with visual impairment (4) Patients with end stage renal failure (5) Cancer receiving chemotherapy (6) Patients with chronic respiratory disease such as obstructive pulmonary disease with home oxygen therapy (7) Patients participating in other clinical trials (8) Patients who need frequent outpatient visit such as blood tests (9) Patients who the principal investigator and co-investigators judged to be medically or scientifically inappropriate to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath